Subtalamotomía bilateral diferida guiada por microrregistros. Resultados motores a un año / Bilateral delayed subtalamotomy guided by micro-records. One-year motor results

Introducción: diferentes técnicas quirúrgicas representan una alternativa para el tratamiento de la enfermedad de Parkinson avanzada (EP). El gran desarrollo en las últimas décadas de modernas técnicas de imágenes sumado a los avances del registro neurofisiológico nos permiten localizar y generar lesiones en forma precisa, con bajo número de complicaciones y excelentes resultados funcionales. Objetivo: Describir los resultados motores obtenidos a los 12 meses post-operatorios de pacientes con diagnóstico de EP avanzada sometidos a subtalamotomía bilateral diferida guiada por microrregistro. Material y Métodos: Se seleccionaron 9 pacientes con diagnóstico de EP avanzada de acuerdo a los criterios de la United Kingdom Parkinson´s Disease Brain Bank, evaluando los efectos de la subtalamotomía bilateral en dos tiempos quirúrgicos. Resultados: Una marcada mejoría de los síntomas cardinales como rigidez, bradicinesia y temblor se observó en todos los pacientes, fundamentalmente en la condición de “off”, y en menor medida también en condición “on”. Se destaca un significativo control de las fluctuaciones motoras y discinesias. Conclusión: La subtalamotomía bilateral diferida guiada por microregistro es un método útil y efectivo en el tratamiento de los síntomas motores de la Enfermedad de Parkinson.

Introduction: in the treatment of advanced Parkinson´s disease (PD) there are different surgical techniques that represent a valid alternative. The development of modern images techniques and neurofisiological recording allow us to generate accurate lesions, with low complications and excellent functional results. Objective: Describe motor results 12 months post-surgical of patients with advanced PD submitted to bilateral and deferred subthalamotomy guided by microrecording. Material and Methods: We selected 9 patients with advanced PD diagnosis in concordance with United Kingdom Parkinson`s Disease Brain Bank criteria, evaluating the effects of bilateral subthalamotomy in two different surgical steps. Results: A marked improvement of cardinal symptoms such as rigidity, bradykinesia and tremor was observed in all patients, fundamentally in “off” condition, and lesser extent in “on” condition. We highlighted a significant control of motor fluctuations and dyskinesias. Conclusion: Bilateral and deferred suthalamotomy guided by microrecording is an effective and useful method in treatment of cardinal motor symptoms of PD.

Do the effects measured by intraoperative and postoperative STN macrostimulation in Parkinson's disease match?

The aim of our study was to compare the results obtained by intraoperative and postoperative subthalamic nucleus (STN) macrostimulation in Parkinson's disease (PD). One hundred three PD patients implanted with bilateral STN stimulation were included. The thresholds for efficacy and side effects (motor contraction; paresthesias; oculomotor signs) observed on the same trajectory and at the same depth during the intraoperative evaluation and the first postoperative setting of STN stimulation parameters were collected. The level of improvement was divided into four categories depending on the degree of rigidity reduction: 0: no effect, A (mediocre efficacy): 20-50%, B (good efficacy): 60-100%, LL: lesion-like effect (disappearance of rigidity after implantation). Efficacy of STN stimulation was analyzed in 83 patients for a total of 664 contacts. For the best effects (B, LL), the results obtained in the operative room were concordant with those of the postoperative evaluation for 81% of the contacts. For the mediocre effects (A) and absence of efficacy, the results were only concordant in 20%. Side effects were analyzed in 103 patients for a total of 824 contacts. In 35% of the tested contacts paresthesias that were absent during surgery were observed postoperatively. This discrepancy was of 17% for the motor and of 10% for oculomotor side effects. Differences between the type of electrodes used, the stimulation parameters employed and the conditions of the assessment could explain these discrepancies.

Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up.

OBJECTIVE: To assess the long-term efficacy and safety of bilateral subthalamic nucleus (STN) stimulation in patients with advanced Parkinson's disease (PD). METHODS: 42 consecutive patients with idiopathic PD treated with bilateral STN stimulation were enrolled. Parkinsonian status, medication intake and neuropsychological evaluation were assessed preoperatively and at 1 and 5 years postoperatively in on and off medication/on and off stimulation conditions. RESULTS: 23 patients could be followed-up 5 years after surgery. In the remaining cases, 5 died, 1 could not be assessed because of device removal for infection, 1 decided not to be stimulated, and 11 were lost of follow-up (one because of a liver carcinoma and the others because they refused the formal four conditions of assessment). STN stimulation reduced the UPDRS motor score by 55 % compared to baseline in the off-medication conditions. Tremor, rigidity, bradykinesia, postural stability, and gait improved by 74 %, 66 %, 59 %, 17 % and 37 %, respectively. UPDRS part II scores were reduced by 38 %. The dopaminergic treatment daily dose was reduced by 54.4 % after surgery. Axial dopa-unresponsive signs worsened in some patients. Among the 42 initial patients we observed the following: 2 brain hemorrhages, 3 infections of the device, 2 phlebitis and 1 pulmonary embolism. In addition, 2 patients needed a repositioning of the electrode. Among the 23 patients followed at 5 years, long lasting side effects consisted in dysarthria (56 %), depression (39 %), eyelid opening apraxia (30.4 %) and apathy (4.3 %). CONCLUSIONS: Our data confirm that bilateral STN stimulation is beneficial in the long-term for PD patients but does not prevent disease progression and the occurence of axial levodopa unresponsive signs in some patients.